Records containing: Primary Progressive Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-05-19Open Label Extension Trial of Idebenone for Primary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-12-24Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-04-18Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-03-22Comparing Gastrointestinal Tolerability and Absorption of Racemic Lipoic Acid and R-lipoic Acid in Progressive Multiple Sclerosis: a Randomized Crossover Trial
-
CLINICAL_TRIALS study record update · 2019-03-07Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-02-20Mitochondrial Dysfunction and Disease Progression
-
CLINICAL_TRIALS study record update · 2018-11-02A Multinational, Multicenter, Randomized, Double Blind, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Once Daily Oral Administration of Laquinimod (0.6 or 1.5 mg) in Patients With Primary Progressive Multiple Sclerosis (PPMS)
-
CLINICAL_TRIALS study record update · 2017-08-30A Phase 1 Open-label Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients With Magnetic Resonance Imaging Evidence of Leptomeningeal Enhancement
-
CLINICAL_TRIALS study record update · 2017-06-14A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg Fingolimod Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis and An Open-label, Single-arm Extension Study to the Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of0.5 mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-09-20Tear Analysis in the Diagnosis of Primary Progressive Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2014-10-27Controlled, Randomized, Double-blind Clinical Trial, 24 Months Duration, to Compare the Efficacy, Safety and Tolerability of Andrographolide Versus Placebo in Patients With Progressive Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-12-07A Phase 2, Open-label, Dose-escalation Study Evaluating the Safety, Tolerability, and Pharmacodynamics of Intravenously Administered MIS416 in Patients With Chronic Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-02-17Natalizumab Treatment of Progressive Multiple Sclerosis